Zhongsheng Xu

Mr. Zhongsheng Xu


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2024 in Nanoscale
Verified
Journal Article
Closed access
PDF file
RLRanran Luo
Ranran Luo
CZChenxi Zhang
Chenxi Zhang
ZZZening Zhang
Zening Zhang
PRPengchen Ren
Pengchen Ren
ZXZhongsheng Xu
Zhongsheng Xu
YLYUN LIU
YUN LIU
This review provides a comprehensive overview of recent biomedical applications of upconversion nanomaterials specifically within the near-infrared two-region (NIR-II) window (1000–1700 nm).

7 September 2019 in Research on Chemical Intermediates
Verified
Journal Article
Closed access
PDF file
TSTao Sun
Tao Sun
MGMingfu Gong
Mingfu Gong
Yuanqing CaiYuanqing Cai
Yuanqing Cai
SXShilin Xiao
Shilin Xiao
ZLZhang Liang
Zhang Liang
CZChunyu Zhou
Chunyu Zhou

12 February 2015 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
GGGuidong Ge
Guidong Ge
JGJinan Gu
Jinan Gu
JYJiangsheng Yu
Jiangsheng Yu
EZEnwei Zhu
Enwei Zhu
JHJiefeng Hai
Jiefeng Hai
Weihua TangWeihua Tang
Weihua Tang
Three dialkylthio benzo[1,2-b:4,5-b′]dithiophene polymers were developed with tuned bandgaps exhibiting a highest PCE value of 5.63% obtained for the polymer solar cells.

12 November 2024 in Talanta
Verified
Journal Article
Closed access
YSYaling Su
Yaling Su
ZXZhongsheng Xu
Zhongsheng Xu
JWJiemin Wang
Jiemin Wang
JQJing Qian
Jing Qian
CLCong Liu
Cong Liu
YLYUN LIU
YUN LIU

5 May 2024 in Talanta
Verified
Journal Article
Closed access
TCTing Cao
Ting Cao
ZXZhongsheng Xu
Zhongsheng Xu
WDWenhua Dong
Wenhua Dong
HMHong Ma
Hong Ma
ZFZhefeng Fan
Zhefeng Fan
YLYUN LIU
YUN LIU

15 February 2026 in Advanced Science
Verified
Journal Article
Open access
ZZZening Zhang
Zening Zhang
CZChenxi Zhang
Chenxi Zhang
RLRanran Luo
Ranran Luo
QWQiuchi Wu
Qiuchi Wu
PRPengchen Ren
Pengchen Ren
YLYUN LIU
YUN LIU
Sepsis‐associated acute kidney injury (SAKI) remains a life‐threatening condition with limited therapeutic options, primarily driven by rampant oxidative stress, inflammatory dysregulation. Importantly, aberrant formation of neutrophil extracellular traps (NETs) and sustained innate immune activation further exacerbate renal injury, highlighting the need for strategies that precisely modulate these intertwined pathological mechanisms. Here, we present neutrophil‐mimetic nanoscavengers (MD@NM) that comprise a catalytic core of DNase‐1‐loaded Mn 3 O 4 nanozymes enveloped by a neutrophil membrane engineered to actively target and simultaneously disrupt multiple pathological circuits in SAKI. The neutrophil membrane confers chemokine‐receptor (e.g., CXCR2) mediated homing to injured kidneys, while the Mn 3 O 4 nanozymes catalytically scavenge ROS and the loaded DNase‐1 enzymatically degrades NETs‐derived extracellular DNA, thereby suppressing the cGAS‐STING pathway and skewing macrophage polarization toward an M2 reparative phenotype. In a murine model of LPS‐induced SAKI, MD@NM treatment facilitated robust renal targeting, attenuated neutrophilic infiltration, resolved cytokine storm, and ameliorated structural kidney damage. Collectively, this biomimetic platform represents a novel strategy for precision immunomodulation and multi‐mechanistic therapy against SAKI by integrating antioxidative, NETs‐scavenging, and anti‐inflammatory functions into a single nanotherapeutic agent.